Burn News and Research

RSS

Thermal Energy receives $10 million in federal stimulus funding

Thermal Energy Corp. (TECO) in Houston announced today that it will receive $10 million in federal stimulus funding for its new combined heat and power project at the Texas Medical Center, where TECO provides district heating and cooling service to 18 institutions.

6 Nov 2009

Neurogen announces financial results for the third quarter of 2009

Neurogen Corporation, a drug development company historically focused on drugs for psychiatric and neurological disorders, today announced financial and operating results for the quarter ended September 30, 2009.

6 Nov 2009

Abiomed reports second quarter fiscal 2010 results

Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced second quarter fiscal 2010 revenue of $20 million.

5 Nov 2009

Stereotaxis reports $13.3 million revenue for third quarter 2009

Stereotaxis, Inc. today reported strong revenue growth, a significant increase in the gross margin, lower operating expenses and a significant reduction in the net loss for both the quarter and the nine month period ended September 30, 2009.

5 Nov 2009

Shionogi files New Drug Application in Japan

BioCryst Pharmaceuticals, Inc. today announced that its partner, Shionogi & Co., Ltd. has filed a New Drug Application (NDA) in Japan to seek regulatory approval for intravenous (i.v.) peramivir to treat patients with influenza. As a consequence of this filing, BioCryst will receive a regulatory milestone payment of $7 million under its agreement with Shionogi.

4 Nov 2009

Arrowhead Research updates its shareholders

Arrowhead Research Corporation’s (NASDAQ: ARWR) President and Chief Executive Officer today issued the following letter to the Company’s shareholders.

3 Nov 2009

Puricore reports increase in sales of 25% in Q3

PuriCore, the life sciences company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment, today issues an Interim Management Statement covering the three-month and nine-month periods ending September 30, 2009.

3 Nov 2009

Gruve, an activity-based weight management solution from Muve

Muve, Inc., the activity-based weight management company, continues to see increased interest in measurable, sustainable wellness solutions by employers trying to reduce employee health care costs. Muve’s product, the Gruve Solution, helps corporate clients and their employees to become more healthy and productive, while reducing health care costs through measurable results.

29 Oct 2009

NMT Medical reports financial results for third-quarter 2009; narrows net loss to $0.22 per share

NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced financial results for the quarter and nine months ended September 30, 2009.

29 Oct 2009

Third-quarter 2009 financial results of Antigenics announced

Antigenics Inc. reported today its results for the quarter ended September 30, 2009. The company incurred a net loss attributable to common stockholders of $10.8 million, or $0.13 per share, basic and diluted, for the third quarter of 2009, compared with a net loss attributable to common stockholders in the third quarter of 2008 of $11.4 million, or $0.17 per share, basic and diluted.

29 Oct 2009

BioCryst Pharmaceuticals reports fiscal 2009 third-quarter results

BioCryst Pharmaceuticals, Inc. announced financial results for the quarter and nine months ended September 30, 2009 and provided a corporate update regarding clinical programs and potential emergency use of intravenous (i.v.) peramivir.

29 Oct 2009

Substantial state and regional variation exist in geographic access to burn centers

Although nearly 80 percent of the U.S. population lives within 2 hours by ground or helicopter transport to a verified burn center, there is substantial state and regional variation in geographic access to these centers, according to a study in the October 28 issue of JAMA.

28 Oct 2009

Fall sports season is one of the most difficult times of the year to maintain a fitness regimen: Survey

According to a new survey conducted by 24 Hour Fitness – the largest privately owned U.S. fitness chain and a leading health club industry pioneer – the fall sports season is one of the most difficult times of the year to maintain a fitness regimen. And even though the results show that people are inspired by their favorite sports and athletes, that inspiration is not translating into action for most Americans.

28 Oct 2009

King Pharmaceuticals receives exclusive rights to market and sell CYANOKIT

King Pharmaceuticals, Inc. announced today that it has licensed from Merck Santé S.A.S., an affiliate of Merck KGaA, Darmstadt, Germany, the exclusive rights to market and sell CYANOKIT® 5 g (hydroxocobalamin for injection) ANTIDOTE in the U.S. CYANOKIT® is indicated for the treatment of known or suspected cyanide poisoning, typically caused by smoke inhalation from fires.

28 Oct 2009

Wound Management Technologies signs distribution agreement with Biocure S.r.l. of Milan

Wound Management Technologies, Inc., through its subsidiary, Wound Care Innovations, announced today that it has reached an agreement with Biocure S.r.l. of Milan, Italy for the distribution of WNDM's patented molecular form of activated collagen, CellerateRx®.

26 Oct 2009

Axolotl launches Elysium Image Exchange

Axolotl Corp., the nationwide leader in health information exchange (HIE) solutions and services, today announced the immediate availability of Elysium Image Exchange, a state-of-the-art technology integrated with Axolotl’s Elysium® Exchange suite of products. Powered by Axolotl’s partner eHealth Global Technologies, Inc. (eHGT), Elysium Image Exchange enables the electronic sharing of diagnostic quality medical images between health care providers participating in an HIE.

26 Oct 2009

Anti-viral drug development programs progress successfully, reports NanoViricides

NanoViricides, Inc. (the "Company"), reports that the Company is well financed and its game changing anti-viral drug development programs are progressing successfully. As such, Management knows of no reason for the recent decline in stock price and associated volatility.

26 Oct 2009

FDA issues emergency use authorization for peramivir anti-viral drug

BioCryst Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA), in response to a request from the U.S. Centers for Disease Control and Prevention (CDC), has issued an emergency use authorization (EUA) for the investigational anti-viral drug intravenous (i.v.) peramivir in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are admitted to a hospital.

24 Oct 2009

ECRI Institute releases important changes to its recommendations for preventing surgical fires

A flash fire on a patient during surgery is a very real tragedy, often leading to disfigurement, disability or even death. Though surgical fires are uncommon--about 550 to 650 occur in the United States each year--their consequences are grave enough to warrant ongoing prevention education by healthcare providers.

23 Oct 2009

COOKIE DIET web site reaches milestone; registers its 100,000th member

At 6:14pm yesterday, Debora Gore of Bristow, Virginia, received a phone call from renowned physician, author, and weight-loss expert Dr. Sanford Siegal who was calling to congratulate her on becoming the 100,000th registered member of CookieDiet.com, the official Dr. Siegal's COOKIE DIET® web site.

22 Oct 2009